“This acquisition affirms our position as the worldwide market leader in neurology. Approximately two-thirds of Alpine Biomed’s revenue is from outside the United States, and Alpine Biomed is the market leader in electromyography diagnostics, or EMG, in Europe with its well established Keypoint product line. In addition, we believe this acquisition signals that our business model that combines internal growth and accretive acquisitions is back on track.”

Natus Medical acquired Water Street’s specialty neurodiagnostic device business, Alpine Biomed, in 2009.